When the Patient’s Story Gets Lost: What Clinical Researchers Need to Know About Narrative Distortion

Every clinical researcher has seen it. A patient comes to a site visit. They describe their experience in detail—the fatigue that started three weeks ago, the way it is different from their usual tiredness, the moment it began affecting their ability to work, the fear underneath it all that the drug might not be working anymore. The coordinator listens, nods, and documents: “Patient reports fatigue. Grade 1. No change from baseline.” The nuance disappears. The timeline disappears. The context disappears. The fear—which might have been the most clinically important signal in the room—disappears entirely. This is narrative distortion. And it is happening in clinical trials every day, in ways that affect data quality, patient safety, and the integrity of the evidence we are building.

Beyond the Hype: Measuring the Value of AI in Clinical Trials

Artificial intelligence (AI) is viewed as a potentially transformative force in the development of new therapies and has helped accelerate the discovery of new molecules. AI is also proving to accelerate the conduct of trials—and not a moment too soon, as the bottleneck in research shifts downstream away from discovery to in-human trials still hampered by operational friction. Now, a new study from the Tufts Center for the Study of Drug Development, conducted in collaboration with Medable, has taken an important step toward gaining critical understanding about how AI can help improve drug development.

Why Choosing an ISO 27001–Certified Company Matters: 7 Key Benefits for Security, Compliance, and Customer Trust

For organizations that handle private and protected data related to healthcare (and other sensitive economic sectors), information security is not just a federally mandated compliance requirement—it should be a core business principle. ISO/IEC 27001:2022 certification demonstrates commitment to upholding the highest standards of security, governance, and operational excellence. By aligning processes, controls, and governance framework with globally recognized best practices, organizations ensure the delivery of secure, trusted, and resilient digital and AI-powered solutions for their clients and partners.

Clinical Research Workforce Attrition is a Planning Failure with a Six-Month Delay

A lot of intertwining forces are at play when it comes to the challenge of retaining talent at any stage of their careers in the clinical research enterprise, but one tactic that should alleviate much of the issues tied to newer hires dropping out with alarming rapidity is learning “not to put the cart before the horse,” says a workforce development observer who will speak to the issue at ACRP 2027 in San Diego.

Scaling Site Networks: Why Infrastructure Must Keep Pace with Growth

We’ve all heard the maxim that “bigger is not better,” but who is really paying attention to it in the clinical research enterprise? One expert observer who will speak at ACRP 2027 in San Diego says that, as clinical research site networks expand through acquisitions, partnerships, new site activations, and geographic growth, the challenge extends beyond increasing the number of locations. She notes that, particularly for advanced and complex therapies, sustainable expansion requires operational infrastructure, governance, and site readiness to keep pace with network growth.